AUTHOR REPLY

Abstract

We thank the author for highlighting the significance of access for early detection and prompt treatment of urologic disease. Healthcare access for Medicaid-insured patients will be important to monitor as private equity acquisitions continue to reshape the urology landscape. In the year since our initial study, at least 1 additional private equity backed platform company has formed and numerous practices have been acquired in roll-up acquisitions. 1 Nie J Demkowicz PC Hsiang W et al. Urology practice acquisitions by private equity firms from 2011–2021. Urol Pract. 2021; https://doi.org/10.1097/UPJ. 0000000000000269 Crossref Google Scholar ,2 S&P Capital IQ. Available at: https://www.capitaliq.com. Accessed March 15, 2021. Google Scholar In addition, the first known “exit” by a private equity firm has occurred with the sale of northeast urology platform to a for-profit, multispecialty physician group. 3 Summit Health. Summit Health Adds Westmed Medical Group and New Jersey Urology, expanding access to its unique connected care model [press release]. 2022. Business Wire. Google Scholar Changes in ownership should underscore to readers that private equity acquisitions are not intended as longitudinal partnerships with physicians or communities but are instead, by design, short-term investment opportunities.